Cognitive changes predict functional decline in ALS: A population-based longitudinal study

Neurology

Volumn 80, Issue 17, 2013, Pages 1590-1597

  Elamin, Marwa ^a   Bede, Peter ^a   Byrne, Susan ^a   Jordan, Norah ^b   Gallagher, Laura ^b   Wynne, Brona ^b   O'Brien, Caoimhe ^b   Phukan, Julie ^a   Lynch, Catherine ^a   Pender, Niall ^b   Hardiman, Orla ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR CHANGE; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE DURATION; EXECUTIVE FUNCTION; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

MLCS; MLOWN;

EID: 84878917082     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828f18ac     Document Type: Article

References (37)

1. Beghi E, Chio A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 2011;12:1-10.
2. Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740-746.
3. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-146.
4. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586-590.
5. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-108.
6. Rosenfeld J, Swash M. What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases. Neurology 2006;66:624-625
7. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263-1269.
8. Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology 1999;53:1665-1670.
9. Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology 2005;64:1222-1226.
10. Kilani M, Micallef J, Soubrouillard C, et al. A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:46-54.
11. Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF. Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry 2006;77:668-670.
12. Moretti R, Torre P, Antonello RM, Carraro N, Cazzato G, Bava A. Complex cognitive disruption in motor neuron disease. Dement Geriatr Cogn Disord 2002;14:141-150.
13. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008;79:30-32.
14. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology 1999;52:504-509.
15. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
16. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
17. Trenerry MR, De Boe J, Leber W. Stroop Neuropsychological Screening Test Manual. Odessa, FL: Psychological Assessment Resources; 1989.
18. Burgess PW, Shallice T. The Hayling and Brixton Tests. Thurston, Suffolk: Thames Valley Test Company; 1997.
19. Meyers JE, Meyers KR. Rey Complex Figure Test and Recognition Trial, Professional Manual. Odessa, FL: Psychological Assessment Resources; 1995.
20. Wechsler D. Wechsler Memory Scale (WMS-III UK): Administration and Scoring Manual, 3rd ed. San Antonio: The Psychological Corporation; 1997.
21. Wechsler D. Wechsler Test of Adult Reading. San Antonio: The Psychological Corporation; 2001.
22. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370.
23. Raven J, Raven JC, Court JH. Raven Manual: Section 2. Coloured Progressive Matrices. Oxford, UK: Oxford Psychologists Press; 1998.
24. Abrahams S, Goldstein LH, Lloyd CM, Brooks DJ, Leigh PN. Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation. J Neurol Sci 1995;129:54-55.
25. Graves RE, Bezeau SC, Fogarty J, Blaire R Boston Naming Test short forms: a comparison of previous forms with new item response theory based forms. J Clin Exp Neuropsychol 2004;26:891-902.
26. Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System. San Antonio: The Psychological Corporation; 2001.
27. Grace J, Stout JC, Malloy PF. Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment 1999;6:269-284.
28. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
29. Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265-267.
30. Gordon PH, Goetz RR, Rabkin JG, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler 2010;11:312-320.
31. Freeman RQ, Giovannetti T, Lamar M, et al. Visuoconstructional problems in dementia: contribution of executive systems functions. Neuropsychology 2000;14:415-426.
32. Bak TH. Motor neuron disease and frontotemporal dementia: one, two, or three diseases? Ann Indian Acad Neurol 2010;13:S81-S88.
33. Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol 2001;248:260-270.
34. Strong MJ, Yang W, Strong WL, Leystra-Lantz C, Jaffe H, Pant HC. Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment. Neurology 2006;66:1770-1771.
35. Yang W, Strong MJ. Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. Amyotroph Lateral Scler 2012;13:178-193.
36. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805-811.
37. Geser F, Prvulovic D, O'Dwyer L, et al. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol 2011;95:649-662.